September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 10, 2025

Medical Societies Challenge Kennedy

"That you can no longer trust the recommendations out of the CDC is just devastating."

Conexiant

September 08, 2025

FDA Expands Indications for Von Willebrand Disease

FDA expands Vonvendi to adult routine prophylaxis (types 1 and 2) and pediatric on-demand/perioperative use.

Conexiant

September 04, 2025

AI Tool Detects Lupus From Eye Scans

DeepSLE uses retinal images to identify systemic lupus erythematosus and related complications with high accuracy across diverse populations, outperforming physicians in a prospective comparison.

Conexiant

September 03, 2025

CDC Leadership Changes May Impact Vaccine Guidance

Leadership changes at the CDC could affect vaccine guidance and public health policy, with potential implications for physicians and patient care.

KFF Health News

September 03, 2025

Study Maps Delta-Like Protein 3 and SEZ6 Across Tumor Types

Researchers highlight distinct Delta-like protein 3 and seizure-related 6 homolog patterns in neuroendocrine tumors.

Conexiant

September 02, 2025

New Bruton’s Tyrosine Kinase Inhibitor Improves Platelet Response

The FDA has approved rilzabrutinib (Wayrilz) as the first Bruton’s tyrosine kinase inhibitor for adults with chronic or persistent immune thrombocytopenia who have had an insufficient response to prior therapy.

Conexiant

August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

CD68/CD163 Mark Worse Outcomes in Skeletal Hodgkin Lymphoma, Study

Skeletal classic Hodgkin lymphoma shows a macrophage-rich, B-cell–poor microenvironment, with high CD68/CD163 linked to worse survival.

Conexiant